Teladoc Health (TDOC) to Release Earnings on Wednesday

Teladoc Health (NYSE:TDOC) will likely be releasing its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect Teladoc Health to post earnings of ($0.26) per share and revenue of $625.6640 million for the quarter. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS.Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 5:00 PM ET.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million during the quarter, compared to analysts’ expectations of $621.91 million. During the same quarter last year, the business posted ($0.38) earnings per share. The firm’s revenue was down 1.6% on a year-over-year basis. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Stock Performance

NYSE:TDOC opened at $9.49 on Monday. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health has a 12-month low of $6.35 and a 12-month high of $15.21. The stock has a 50-day moving average price of $8.11 and a 200 day moving average price of $7.67. The stock has a market capitalization of $1.68 billion, a P/E ratio of -7.97 and a beta of 1.90.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a research note on Friday. Evercore ISI increased their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Wednesday, October 8th. Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They set a “neutral” rating and a $10.00 price target for the company. Zacks Research raised Teladoc Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 10th. Finally, Citigroup increased their price target on Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a research note on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $9.97.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bridgeway Capital Management LLC bought a new stake in shares of Teladoc Health during the 2nd quarter worth approximately $8,729,000. Quantinno Capital Management LP increased its holdings in Teladoc Health by 39.2% during the 2nd quarter. Quantinno Capital Management LP now owns 596,260 shares of the health services provider’s stock worth $5,193,000 after purchasing an additional 167,960 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Teladoc Health by 5.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider’s stock worth $3,566,000 after purchasing an additional 24,124 shares during the period. Engineers Gate Manager LP increased its holdings in Teladoc Health by 49.4% during the 2nd quarter. Engineers Gate Manager LP now owns 397,531 shares of the health services provider’s stock worth $3,462,000 after purchasing an additional 131,492 shares during the period. Finally, Brevan Howard Capital Management LP increased its holdings in Teladoc Health by 1,540.1% during the 2nd quarter. Brevan Howard Capital Management LP now owns 332,299 shares of the health services provider’s stock worth $2,894,000 after purchasing an additional 312,038 shares during the period. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.